302872, Knoll, Germany) both in a dose of reduce SBP significantly (Co, 133±5; SNX, 144±8;  ET-A, 132±8; ET-AB, 140±6m m H g ;N S ) .U r i n a r y 30 mg/kg/day orally in the drinking water for 12 weeks (n=5-7). The administration of the ET receptor antag-protein excretion was increased 20-fold in untreated SNX animals after 12 weeks compared with controls onists was started 2 days after nephrectomy. Body weight, food and water intake and systolic blood (P<0.01). Both ET receptor antagonists were able to reduce proteinuria in SNX rats, whereas the selective pressure (SBP) were determined prior to operation and at 2 week intervals during the experiment. Blood ET A receptor antagonist reduced proteinuria to a greater extent than the combined ET AB receptor antagonist pressure measurements were made in conscious animals by tail plethysmography. Blood was obtained from the (proteinuria: CO, 6±2; SNX, 92±9; ET-A, 27±2; ET-AB, 43±6mg/24 h; P<0.01). The hypertrophy of tail vein to determine haematocrit, serum creatinine, serum urea, plasma ET-1 and aldosterone. At the same the heart in untreated SNX rats was prevented significantly by both ET receptor antagonists. The plasma time intervals, the rats were placed into individual metabolic cages and 24 h urine collections were per-aldosterone showed an activation in untreated SNX rats, being completely antagonized by ET AB but not by formed to determine urine volume, proteinuria and immunoreactive ET-1 concentration. The experiment ET A receptor antagonist. was terminated after 12 weeks. The weight of the kidney and the heart was measured. Data are expressed Summary as means±SEM and were analysed statistically using Student's Newman Keul test. P-values <0.05 were considered to denote statistically significant differences. The present study suggests that ET-1 is involved in the pathogenesis of uraemic cardiac hypertrophy and in the progression of renal failure in rats with subtotal nephrec-
Results
tomy examined after an intermediate period of 12 weeks of renal failure. Furthermore, proteinuria is reduced by the selective ET A receptor antagonist more than by the SNX animals showed a significant increase of serum creatinine (P<0.01) and urea 12 weeks after nephrec-unselective ET AB receptor antagonist, without reducing the blood pressure. ET receptor blockade might preserve tomy as compared with sham-operated animals. During the 12 weeks of the experiment, there was a continuous renal function by reduction of protein excretion. In addition, ET receptor antagonists influence the aldosincrease in ET-1 excretion in the urine (2-to 3-fold) in SNX animals. A maximum was reached after 8 weeks terone system. In our animal studies, the medication was well tolerated. Our study results provide a possible without any further significant increase compared with controls (P<0.01). The ET A and ET AB receptor antag-therapeutic approach using ET receptor antagonists for cardiac hypertrophy and renal protein excretion by onist-treated rats showed a delayed elevation of urinary ET excretion. In contrast, the plasma ET was not blockade of endogenous ET-1.
Further human studies are needed to show whether elevated in untreated SNX rats, whereas the treated SNX animals showed a marked increase. There was this protection of the heart and kidney might influence the survival and life expectancy of patients suffering only a slight elevation in SBP in untreated SNX animals after 12 weeks compared with sham-operated controls. from chronic renal failure, of patients on dialysis or after kidney transplantation. The decrease in diurnal rhythm of blood pressure and and mortality [1, 2] . In our earlier study, we found a close correlation between serum DHEAS levels and low plasma dehydroepiandrosterone sulfate (DHEAS ) diurnal indices in normotensive volunteers and in levels are strong predictors of cardiovascular morbidity patients with essential hypertension [3] . The aim of the study was to determine the relationship between DHEAS was done by a radioimmunoassay technique [4] . The prevalence of reversed systolic/diastolic diurnal indices was 2/2% in normotension, 25/25% in particularly dominant in patients after renal trans-RH and 48/33% in TPX patients (P%0.001 with x2 plantation. test). We found significant correlations between systolic and diastolic indices, and serum DHEAS levels in the
